Atlas Trials

Developing Clinical Tools to Communicate Genetic Risk for Individuals Who Are Clinical High Risk for Psychosis

Clinical trial NCT04325568 · COMPLETED

Trial details

NCT number
NCT04325568
Sponsor
New York University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Psychosis
Start date
2020-11-16
Primary completion
2022-07-31
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.